Literature DB >> 31853507

Histone Chaperone FACT and Curaxins: Effects on Genome Structure and Function.

Han-Wen Chang1, Ekaterina V Nizovtseva1, Sergey V Razin2,3, Tim Formosa4, Katerina V Gurova5, Vasily M Studitsky1,3.   

Abstract

The histone chaperone FACT plays important roles in essentially every chromatin-associated process and is an important indirect target of the curaxin class of anti-cancer drugs. Curaxins are aromatiс compounds that intercalate into DNA and can trap FACT in bulk chromatin, thus interfering with its distribution and its functions in cancer cells. Recent studies have provided mechanistic insight into how FACT and curaxins cooperate to promote unfolding of nucleosomes and chromatin fibers, resulting in genome-wide disruption of contact chromatin domain boundaries, perturbation of higher order chromatin organization, and global disregulation of gene expression. Here, we discuss the implications of these insights for cancer biology.

Entities:  

Keywords:  chromatin structure; genomics; nucleosomes; transcription

Year:  2019        PMID: 31853507      PMCID: PMC6919649          DOI: 10.20517/2394-4722.2019.31

Source DB:  PubMed          Journal:  J Cancer Metastasis Treat        ISSN: 2394-4722


  92 in total

1.  Protein kinase CK2 phosphorylates the high mobility group domain protein SSRP1, inducing the recognition of UV-damaged DNA.

Authors:  Nicholas M Krohn; Christian Stemmer; Peter Fojan; Rudi Grimm; Klaus D Grasser
Journal:  J Biol Chem       Date:  2003-02-04       Impact factor: 5.157

2.  The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryos.

Authors:  Shang Cao; Heather Bendall; Geoffrey G Hicks; Abudi Nashabi; Hitoshi Sakano; Yoichi Shinkai; Marisa Gariglio; Eugene M Oltz; H Earl Ruley
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

3.  Mutations in SPT16/CDC68 suppress cis- and trans-acting mutations that affect promoter function in Saccharomyces cerevisiae.

Authors:  E A Malone; C D Clark; A Chiang; F Winston
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast Differentiation.

Authors:  Tareq Hossan; Sankari Nagarajan; Simon J Baumgart; Wanhua Xie; Roberto Tirado Magallanes; Céline Hernandez; Pierre-Marie Chiaroni; Daniela Indenbirken; Melanie Spitzner; Morgane Thomas-Chollier; Marian Grade; Denis Thieffry; Adam Grundhoff; Florian Wegwitz; Steven A Johnsen
Journal:  Stem Cells       Date:  2016-02-13       Impact factor: 6.277

5.  FACT Disrupts Nucleosome Structure by Binding H2A-H2B with Conserved Peptide Motifs.

Authors:  David J Kemble; Laura L McCullough; Frank G Whitby; Tim Formosa; Christopher P Hill
Journal:  Mol Cell       Date:  2015-10-08       Impact factor: 17.970

6.  The Modifier of Transcription 1 (Mot1) ATPase and Spt16 Histone Chaperone Co-regulate Transcription through Preinitiation Complex Assembly and Nucleosome Organization.

Authors:  Jason D True; Joseph J Muldoon; Melissa N Carver; Kunal Poorey; Savera J Shetty; Stefan Bekiranov; David T Auble
Journal:  J Biol Chem       Date:  2016-05-16       Impact factor: 5.157

7.  The yeast and human FACT chromatin-reorganizing complexes solve R-loop-mediated transcription-replication conflicts.

Authors:  Emilia Herrera-Moyano; Xénia Mergui; María L García-Rubio; Sonia Barroso; Andrés Aguilera
Journal:  Genes Dev       Date:  2014-03-17       Impact factor: 11.361

8.  Modulation of chromatin structure by the FACT histone chaperone complex regulates HIV-1 integration.

Authors:  Julien Matysiak; Paul Lesbats; Eric Mauro; Delphine Lapaillerie; Jean-William Dupuy; Angelica P Lopez; Mohamed Salah Benleulmi; Christina Calmels; Marie-Line Andreola; Marc Ruff; Manuel Llano; Olivier Delelis; Marc Lavigne; Vincent Parissi
Journal:  Retrovirology       Date:  2017-07-28       Impact factor: 4.602

9.  The anti-cancer drugs curaxins target spatial genome organization.

Authors:  Omar L Kantidze; Artem V Luzhin; Ekaterina V Nizovtseva; Alfiya Safina; Maria E Valieva; Arkadiy K Golov; Artem K Velichko; Alexander V Lyubitelev; Alexey V Feofanov; Katerina V Gurova; Vasily M Studitsky; Sergey V Razin
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

10.  Defective transcription elongation in a subset of cancers confers immunotherapy resistance.

Authors:  Vishnu Modur; Navneet Singh; Vakul Mohanty; Eunah Chung; Belal Muhammad; Kwangmin Choi; Xiaoting Chen; Kashish Chetal; Nancy Ratner; Nathan Salomonis; Matthew T Weirauch; Susan Waltz; Gang Huang; Lisa Privette-Vinnedge; Joo-Seop Park; Edith M Janssen; Kakajan Komurov
Journal:  Nat Commun       Date:  2018-10-23       Impact factor: 14.919

View more
  3 in total

1.  ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis.

Authors:  Ting Zhang; Chaoran Yin; Aleksandr Fedorov; Liangjun Qiao; Hongliang Bao; Nazar Beknazarov; Shiyu Wang; Avishekh Gautam; Riley M Williams; Jeremy Chase Crawford; Suraj Peri; Vasily Studitsky; Amer A Beg; Paul G Thomas; Carl Walkley; Yan Xu; Maria Poptsova; Alan Herbert; Siddharth Balachandran
Journal:  Nature       Date:  2022-05-25       Impact factor: 69.504

Review 2.  The histone chaperone FACT: a guardian of chromatin structure integrity.

Authors:  Célia Jeronimo; François Robert
Journal:  Transcription       Date:  2022-04-29

Review 3.  The role of FACT in managing chromatin: disruption, assembly, or repair?

Authors:  Tim Formosa; Fred Winston
Journal:  Nucleic Acids Res       Date:  2020-12-02       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.